CSIMarket
 


Si bone inc   (SIBN)
Other Ticker:  
 
 

SIBN's Capital Expenditures Growth by Quarter and Year

Si Bone Inc 's Capital Expenditures results by quarter and year




SIBN Capital Expenditures (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 1.09 1.66 1.78 0.82
III Quarter September 1.41 3.57 0.42 0.48
II Quarter June 2.71 2.00 2.22 0.38
I Quarter March 2.58 2.27 1.98 0.88
FY   7.79 9.50 6.40 2.56



SIBN Capital Expenditures fourth quarter 2023 Y/Y Growth Comment
Si Bone Inc reported fall in Capital Expenditures in the fourth quarter 2023 by -34.16% to $ 1.09 millions, from the same quarter in 2022.
The drop in the fourth quarter 2023 Si Bone Inc 's Capital Expenditures compares unfavorably to the Company's average Capital Expenditures jump of 71.82%.

Looking into fourth quarter 2023 results within Medical Equipment & Supplies industry 34 other companies have achieved higher Capital Expenditures growth. While Si Bone Inc ' s Capital Expenditures drop of -34.16% ranks overall at the positon no. 781 in the fourth quarter 2023.




SIBN Capital Expenditures ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December -34.16 % -6.74 % 117.07 % 1.23 %
III Quarter September -60.5 % 750 % -12.5 % -70.73 %
II Quarter June 35.5 % -9.91 % 484.21 % -
I Quarter March 13.66 % 14.65 % 125 % -
FY   -17.97 % 48.44 % 150 % 4.49 %

Financial Statements
Si Bone Inc 's fourth quarter 2023 Capital Expenditures $ 1.09 millions SIBN's Income Statement
Si Bone Inc 's fourth quarter 2022 Capital Expenditures $ 1.66 millions Quarterly SIBN's Income Statement
New: More SIBN's historic Capital Expenditures Growth >>


SIBN Capital Expenditures (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December -22.48 % -53.5 % 323.81 % 70.83 %
III Quarter September -47.97 % 78.5 % -81.08 % 26.32 %
II Quarter June 5.04 % -11.89 % 12.12 % -56.82 %
I Quarter March 55.42 % 27.53 % 141.46 % 8.64 %
FY (Year on Year)   -17.97 % 48.44 % 150 % 4.49 %




Capital Expenditures fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #35
Healthcare Sector #92
Overall #781

Capital Expenditures Y/Y Growth Statistics
High Average Low
313.24 % 71.82 % -17.97 %
(Mar 31 2021)   (Dec 31 2023)
Capital Expenditures fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #35
Healthcare Sector #92
Overall #781
Capital Expenditures Y/Y Growth Statistics
High Average Low
313.24 % 71.82 % -17.97 %
(Mar 31 2021)   (Dec 31 2023)

Capital Expenditures by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Si Bone Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
319.62 % 24.83 % -80.9 %
(Dec 31 2021)  


SIBN's IV. Quarter Q/Q Capital Expenditures Comment
In the IV. Quarter 2023 Si Bone Inc reported fall in Capital Expenditures sequentially by -22.48% to $ 1.09 millions, from $ 1.41 millions declared in the previous quarter.

As we analyse present shortcoming in the IV. Quarter 2023, we must presume, that usually IV. Quarter Capital Expenditures occur weaker then in the preciding period

Within Medical Equipment & Supplies industry 61 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Si Bone Inc 's Capital Expenditures growth quarter on quarter, overall rank is 1235.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #62
Healthcare Sector #155
Overall #1235
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #62
Healthcare Sector #155
Overall #1235
Capital Expenditures Q/Q Growth Statistics
High Average Low
319.62 % 24.83 % -80.9 %
(Dec 31 2021)  


SIBN's IV. Quarter Q/Q Capital Expenditures Comment
In the IV. Quarter 2023 Si Bone Inc reported fall in Capital Expenditures from the previous quarter by -22.48% to $ 1.09 millions, from $ 1.41 millions declared a quarter before.

As we look into current shortcoming at the IV. Quarter, we must take into consideration, that frequently IV. Quarter performance appear to be weaker then in the third quarter

Within Medical Equipment & Supplies industry 61 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Si Bone Inc 's Capital Expenditures growth quarter on quarter, overall rank is 1235.


Si Bone Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Capital Expenditures 12 Months Ending $ 7.80 $ 8.37 $ 10.53 $ 9.81 $ 9.51
Y / Y Capital Expenditures Growth (TTM) -17.97 % -13.05 % 62.6 % 46.73 % 48.8 %
Year on Year Capital Expenditures Growth Overall Ranking # 203 # 345 # 906 # 55 # 236
Seqeuential Capital Expenditures Change (TTM) -6.78 % -20.51 % 7.27 % 3.21 % -1.2 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 781 # 545 # 1287 # 1326 # 1189




Cumulative Capital Expenditures growth Comment
Si Bone Inc 's cumulative 12 months Capital Expenditures continue to fall, but on the faster rate at -17.97% year on year, at Dec 31 2023 compare to the -13.05% decrease at Sep 30 2023. If the Si Bone Inc 's fiscal year would end at Dec 31 2023, annual Capital Expenditures would be $8 millions.

Within the Healthcare sector 29 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 203, from total ranking in previous quarter at 345.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
313.24 %
71.82 %
-17.97 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 35
Healthcare Sector # 30
Overall # 203

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
313.24 %
71.82 %
-17.97 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 35
Sector # 92
S&P 500 # 781
Cumulative Capital Expenditures growth Comment
Si Bone Inc 's cumulative 12 months Capital Expenditures continue to fall, but on the faster rate at -17.97% year on year, at Dec 31 2023 compare to the -13.05% decrease at Sep 30 2023. If the Si Bone Inc 's fiscal year would end at Dec 31 2023, annual Capital Expenditures would be $8 millions.

Within the Healthcare sector 29 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 203, from total ranking in previous quarter at 345.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
313.24 %
71.82 %
-17.97 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 35
Healthcare Sector # 30
Overall # 203

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
313.24 %
71.82 %
-17.97 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 35
Sector # 92
S&P 500 # 781




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
SIBN's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for SIBN's Competitors
Capital Expenditures Growth for Si Bone Inc 's Suppliers
Capital Expenditures Growth for SIBN's Customers

You may also want to know
SIBN's Annual Growth Rates SIBN's Profitability Ratios SIBN's Asset Turnover Ratio SIBN's Dividend Growth
SIBN's Roe SIBN's Valuation Ratios SIBN's Financial Strength Ratios SIBN's Dividend Payout Ratio
SIBN's Roa SIBN's Inventory Turnover Ratio SIBN's Growth Rates SIBN's Dividend Comparisons



Companies with similar Capital Expenditures fall for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Dec 31 2023
Sunshine Biopharma Inc -0.43%$ -0.431 millions
Stereotaxis Inc -0.81%$ -0.813 millions
Icon Plc-1.03%$ -1.033 millions
Alpine Immune Sciences Inc -1.72%$ -1.724 millions
Argenx se-2.99%$ -2.987 millions
Abbvie inc -3.76%$ -3.756 millions
Vanda Pharmaceuticals Inc -3.80%$ -3.802 millions
Warby Parker Inc -4.52%$ -4.516 millions
Bristol myers Squibb Company-4.62%$ -4.624 millions
Baxter International Inc -5.00%$ -5.000 millions
Progyny Inc -5.55%$ -5.548 millions
Koru Medical Systems Inc-6.92%$ -6.916 millions
Ufp Technologies Inc -7.02%$ -7.018 millions
Bio rad Laboratories Inc -7.27%$ -7.272 millions
Endo International Plc-8.13%$ -8.130 millions
Eterna Therapeutics Inc -9.52%$ -9.524 millions
Sotera Health Company-9.63%$ -9.633 millions
Hutchmed china Limited-11.05%$ -11.052 millions
Petvivo Holdings Inc-11.46%$ -11.461 millions
Novartis Ag-11.52%$ -11.519 millions
Charles River Laboratories International inc -12.02%$ -12.020 millions
Surgery Partners Inc -12.78%$ -12.775 millions
Xbiotech Inc -12.88%$ -12.879 millions
Conmed Corporation-14.46%$ -14.464 millions
Msa Safety Incorporated-14.60%$ -14.601 millions
Teva Pharmaceutical Industries Limited-16.20%$ -16.197 millions
Genedx Holdings Corp -16.28%$ -16.279 millions
Dexcom Inc -17.32%$ -17.323 millions
Davita Inc -17.74%$ -17.739 millions
Voyager Therapeutics Inc -19.08%$ -19.078 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com